A first-in-human phase I study of the PD-1 inhibitor, retifanlimab (INCMGA00012), in patients with advanced solid tumors (POD1UM-101)
| Autor: | Lakhani, N., Cosman, R., Banerji, U., Rasco, D., Tomaszewska-Kiecana, M., Garralda, E., Kornacki, D., Li, J., Tian, C., Bourayou, N., Powderly, J. |
|---|---|
| Zdroj: | In ESMO Open April 2024 9(4) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|